about
A mitochondrial-targeted coenzyme q analog prevents weight gain and ameliorates hepatic dysfunction in high-fat-fed miceMitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cellsCaMKII determines mitochondrial stress responses in heartReversibility of fenofibrate therapy-induced renal function impairment in ACCORD type 2 diabetic participants.Feeding frequency and appetite in lean and obese prepubertal children.The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD studySuperoxide production by mitochondria of insulin-sensitive tissues: mechanistic differences and effect of early diabetes.Mitochondrial dysfunction in diabetes: from molecular mechanisms to functional significance and therapeutic opportunities.Leptin gene -2548G/A variants predict risperidone-associated weight gain in children and adolescents.Lipotoxicity and glucotoxicity in type 2 diabetes. Effects on development and progression.Endothelial cell and platelet bioenergetics: effect of glucose and nutrient composition.Human iPS cell-derived insulin producing cells form vascularized organoids under the kidney capsules of diabetic miceMitochondrial superoxide and coenzyme Q in insulin-deficient rats: increased electron leakEctopic brown adipose tissue in muscle provides a mechanism for differences in risk of metabolic syndrome in miceUnderstanding insulin resistance. What are the clinical implications?Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapyPeroxisome proliferator-activated receptor γ decouples fatty acid uptake from lipid inhibition of insulin signaling in skeletal muscleVoltage-Dependent Regulation of Complex II Energized Mitochondrial Oxygen Flux.Bioenergetic effects of mitochondrial-targeted coenzyme Q analogs in endothelial cellsMitochondrial function in diabetes: novel methodology and new insightEndogenous peroxisome proliferator-activated receptor-gamma augments fatty acid uptake in oxidative muscle.Glycation and carboxymethyllysine levels in skin collagen predict the risk of future 10-year progression of diabetic retinopathy and nephropathy in the diabetes control and complications trial and epidemiology of diabetes interventions and complicatSuperoxide and respiratory coupling in mitochondria of insulin-deficient diabetic ratsReceptor-mediated regional sympathetic nerve activation by leptin.Metabolic effects of a mitochondrial-targeted coenzyme Q analog in high fat fed obese mice.Dietary fat, fatty acid saturation and mitochondrial bioenergetics.UCP2-dependent proton leak in isolated mammalian mitochondria.Sympathetic and cardiorenal actions of leptin.Cardiovascular consequences of obesity: role of leptin.Effect of acute and antecedent hypoglycemia on sympathetic neural activity and catecholamine responsiveness in normal rats.Does leptin stimulate nitric oxide to oppose the effects of sympathetic activation?Differential modulation of leptin-induced sympathoexcitation by baroreflex activation.Leptin and body fat in type 2 diabetes and monodrug therapy.Leptin administration to normal rats does not alter catecholamine responsiveness to insulin-induced hypoglycemia.Cyclic changes in glycemia assessed by continuous glucose monitoring system during multiple complete menstrual cycles in women with type 1 diabetes.Respiratory uncoupling by UCP1 and UCP2 and superoxide generation in endothelial cell mitochondria.Free fatty acid-induced beta-cell defects are dependent on uncoupling protein 2 expression.Adiponectin and C-reactive protein in obesity, type 2 diabetes, and monodrug therapy.Simultaneous quantification of mitochondrial ATP and ROS production.Antecedent hypoglycemia, catecholamine depletion, and subsequent sympathetic neural responses.
P50
Q28383079-CACF3153-3C79-4F20-A65D-0C911C14AD31Q28474562-286A15CC-30ED-4EB5-A408-38C387B4852CQ28591986-D5FE8955-895F-4F5C-A295-74E003475E72Q30419512-6658B500-5446-40B2-9494-E5688BCA9DEBQ30828866-FC97CE20-D13D-4511-A3B2-11EDE597A1D5Q33579765-9E59AE7F-7F24-4D67-B913-2E5C00030883Q33618562-D3E46448-C6AC-42D0-BA22-B81664E7D41DQ33668501-F2EE258D-282D-42B6-A54C-CFBE2442892DQ34056408-C37B8D1F-74D9-4CF0-BB8A-21A81E61B89DQ34228824-3FCFBE0B-C895-4939-AFE9-3A2FAA754298Q34321394-340E0AC0-12B1-4FD8-8EE0-06268E64C284Q35550611-0AB26F40-A412-4C82-9851-792AC2FDECD2Q35601557-17DE0596-5513-44B0-9663-B0096C7FEA5DQ35844663-F7F19BFA-9CA1-4EE3-B5BE-1AC650389CC0Q35845733-BB49FBAC-034F-44FD-9208-93B4A0174B3CQ35875974-E96CC535-AE93-4AEA-8B05-FE56B0CC384DQ35970084-B6B0CEA9-B14F-49C2-9C94-23BFD85FAEF3Q36010913-7A572B31-1361-47B1-8524-30B077A13B74Q36174209-A4C2B054-D94F-4946-8AB6-995DBEF45CB9Q36867599-96AF151C-2DEB-4A61-8442-7DD85158F3E0Q36976374-C7F237D4-96FF-4B4B-8648-ABA9307993E8Q37054987-84791177-E793-4D83-BC1A-7D273770118AQ37072761-1868B0FC-1DD2-47D5-BCB3-0C9994B87846Q37369894-1ADD178F-4A07-4040-B5E2-2C4562B54D60Q37724298-8C6F68BB-E297-4321-9213-5E6A7B6BD84BQ38283640-812689C1-C47B-48E6-9C58-4E81CA859112Q40766544-A7FCAC7C-476A-4D31-B860-C4FBCC7F3091Q41607086-D65D085B-36B3-44EB-971D-4F2269B5F0FBQ41716970-113C22B1-56CA-46A9-A5FA-BE708D34F2E2Q43596026-20332303-2B86-476A-AC32-D34AFB49F83EQ43801306-E239E802-8189-4E8B-A55A-2CB2E09A0D85Q44097643-435594BD-137B-4005-A8E9-458450C1ED46Q44392857-D7528685-6BE4-4C0D-B30A-09AFF90AFAB8Q44660103-53479D3D-5FC2-49BC-900A-736191655E9DQ45024403-0FBC392E-B742-4964-AD75-C9902ED0BDA4Q45038510-F4E5ED71-075F-4A3D-B46D-A55D44A6E0A2Q45078045-00FE0561-1B1C-45EE-927E-48AD200AAFBEQ45146146-8F9FA6E5-8A74-41D5-BB1A-015066CEB2F0Q46780762-4386A4CB-481C-4657-A9F4-848A8CFCAC92Q46983611-B06819CA-F29F-4F92-B757-FAAA31282BDA
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
William Sivitz
@ast
William Sivitz
@en
William Sivitz
@es
William Sivitz
@nl
type
label
William Sivitz
@ast
William Sivitz
@en
William Sivitz
@es
William Sivitz
@nl
prefLabel
William Sivitz
@ast
William Sivitz
@en
William Sivitz
@es
William Sivitz
@nl
P106
P1153
7004430948
P21
P31
P496
0000-0002-7829-0189